(from the application): A multi-disciplinary approach is proposed in this Program Project to define and characterize the signal transduction pathways by which insulin and the gonadal hormones, estrogen and testosterone, regulate the metabolic fate of the Alzheimer precursor protein (APP) and influence beta-amyloid peptide (ABeta) formation and deposition. A greater understanding of the molecular mechanisms which are responsible for these effects should lead to novel therapeutic targets for the treatment of Alzheimer's disease (AD). A broad range of studies will be performed at distinct levels of organizational complexity to define the effects of the hormonal regulation of APP/ABeta metabolism, encompassing in vitro biochemical studies with purified enzymes and other molecules cellular and cell-free systems that accommodate experimental manipulation, and studies in intact animals analyzing both biochemical and morphological changes in APP/ABeta metabolism that can be observed as consequence of the experimental depletion and replacement of the hormones. Scientific Core is designed to provide a reliable source for the production and supply of animals cultured neurons, antibodies and other key reagents and the performance of routine, yet essential tasks that will be required to accomplish the studies described in the research Projects. The centralized organization of support functions will facilitate an efficient and cost-effective means to ensure an adequate supply of materials. The Core staff will maintain the colonies of transgenic AD mice and perform genotyping of offspring (Specific Aim 1), maintain stocks of reagents in current use (Specific Aim 2), and will be responsible for the design screening, and purification of new polyclonal antibodies that are required, including epitope-, domain-, and phosphorylation state-specific antibodies to APP/ABeta fragments and? the cdk5/p35/p25 enzyme complex (Specific Aim 3). The Core will maintain a tissue culture facility to provide a continuous supply of primary cultures of rat and mouse embryonic neurons to all three Projects (Specific Aim 4).

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG009464-12
Application #
6599981
Study Section
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Bettayeb, Karima; Hooli, Basaraj V; Parrado, Antonio R et al. (2016) Relevance of the COPI complex for Alzheimer's disease progression in vivo. Proc Natl Acad Sci U S A 113:5418-23
Bettayeb, Karima; Chang, Jerry C; Luo, Wenjie et al. (2016) ?-COP modulates A? peptide formation via retrograde trafficking of APP. Proc Natl Acad Sci U S A 113:5412-7
Liebmann, Thomas; Renier, Nicolas; Bettayeb, Karima et al. (2016) Three-Dimensional Study of Alzheimer's Disease Hallmarks Using the iDISCO Clearing Method. Cell Rep 16:1138-1152
Ceglia, Ilaria; Reitz, Christiane; Gresack, Jodi et al. (2015) APP intracellular domain-WAVE1 pathway reduces amyloid-? production. Nat Med 21:1054-9
Tian, Yuan; Chang, Jerry C; Greengard, Paul et al. (2014) The convergence of endosomal and autophagosomal pathways: implications for APP-CTF degradation. Autophagy 10:694-6
Chiba, Kyoko; Araseki, Masahiko; Nozawa, Keisuke et al. (2014) Quantitative analysis of APP axonal transport in neurons: role of JIP1 in enhanced APP anterograde transport. Mol Biol Cell 25:3569-80
Hochard, Arnaud; Oumata, Nassima; Bettayeb, Karima et al. (2013) Aftins increase amyloid-?42, lower amyloid-?38, and do not alter amyloid-?40 extracellular production in vitro: toward a chemical model of Alzheimer's disease? J Alzheimers Dis 35:107-20
Tian, Yuan; Chang, Jerry C; Fan, Emily Y et al. (2013) Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci U S A 110:17071-6
Oh, Yong-Seok; Gao, Pu; Lee, Ko-Woon et al. (2013) SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. Cell 152:831-43
Bettayeb, Karima; Oumata, Nassima; Zhang, Yuanyuan et al. (2012) Small-molecule inducers of Aýý-42 peptide production share a common mechanism of action. FASEB J 26:5115-23

Showing the most recent 10 out of 115 publications